Work

Phase IB trial of picibanil (OK-432) as an immunomodulator in patients with resected high-risk melanoma

Year: 1997

Type: article

Source: Cancer Immunology Immunotherapy

DOI: 10.1007/s002620050366

Authors: John M. Kirkwood, John Wilson, Theresa L. Whiteside, Sandra Donnelly, Ronald B. Herberman

Institutions: University of Pittsburgh, UPMC Hillman Cancer Center

Language: English

Topic: Cutaneous Melanoma Detection and Management

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W1981577524

FWCI: 0.999

Cites: 10

Cited by: 21

Related to: 10